InvestorsHub Logo
Followers 74
Posts 3841
Boards Moderated 0
Alias Born 11/12/2010

Re: Black Solvency post# 871

Thursday, 10/29/2020 7:48:09 PM

Thursday, October 29, 2020 7:48:09 PM

Post# of 1889

"Ampio’s lead drug, Ampion, is backed by an extensive patent portfolio with intellectual property protection extending through 2032, and will be eligible for 12-year FDA market exclusivity upon approval as a novel biologic under the biologics price competition and innovation act (“BPCIA”)."



SOURCE: ENGLEWOOD, Colo., October 28, 2020, /PRNewswire/UPDATE ON COVID-19 CLINICAL TRIAL ACTIVITIES.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMPE News